A multicenter, open-label study on the efficacy, cycle control and safety of a contraceptive vaginal ring delivering a daily dose of 150 Ug of Nestorone [elcometrine] and 15 Ug of ethinyl estradiol.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 04 Nov 2015
At a glance
- Drugs Estradiol/elcometrine (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 22 Sep 2015 Sub-study results published in the Contraception.
- 15 Mar 2012 Planned end date changed from 1 Jun 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 21 Jul 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.